openPR Logo
Press release

Aminoglycosides Market Expected to Generate Huge Profits by 2017 – 2025 : Persistence Market Research

06-22-2017 12:38 PM CET | Health & Medicine

Press release from: Persistence Market Research

Aminoglycosides Market Expected to Generate Huge Profits

Aminoglycosides are highly potent, antibiotics with several properties for the treatment of life-threatening infections. Aminoglycosides have concentration-dependent bactericidal activity by binding to the 30S ribosome that inhibits bacterial protein synthesis. Spectinomycin is a bacteriostatic antibiotic chemically related to the aminoglycosides. Protein binding of aminoglycosides antibiotics is less than 10%. Aminoglycosides are poorly absorbed through oral administration, where as they are well absorbed through pleural cavity, joints and peritoneum regions. Aminoglycosides are polar drugs and the distribution is mainly restricted to extracellular fluids except for vitreous humor, cerebrospinal fluid (CSF), respiratory secretions, and bile. The distribution volume of aminoglycosides is approximately 20-25% of body weight. Modification of distribution coefficient of aminoglycosides occurs in patients suffering from gram negative sepsis and are dehydration, hematological disorders, burned patients, etc. Aminoglycosides are primarily excreted through the kidney by glomerular filtration. The 80%-90% of the administered dose is excreted in the urine resulting in high urinary concentrations.

Aminoglycosides are more active against gram-negative, aerobic and facultative anaerobic bacilli. Increase in disease indication due to bacterial infections such as Plasmodium aeruginosa, Serratia marcescens, and increase in incidence of tuberculosis among emerging regions such as Asia Pacific and Middle East & Africa which are expected to boost growth of the global aminoglycosides market. According to the World Health Organization (WHO) 2013, there were 368 Mn people with hearing impairment disorder due to tuberculosis. The prevalence of hearing loss both in children as well as in adults over 65 years of age was highest in South East Asia, Asia Pacific and Sub-Saharan Africa. Hence, the use of aminoglycosides in tuberculosis treatment is expected to fuel growth of aminoglycosides market in these regions through 2024. Renal toxicity, vestibular and auditory toxicity side-effects are expected to hamper the global aminoglycoside market growth during the forecast period.

Aminoglycoside market has been segmented by product type, by disease indication, by route of administration and by geography. In terms of product type aminoglycoside market is classified into natural aminoglycosides such as gentamicin, neomycin, kanamycin and tobramycin, and semisynthetic aminoglycosides such as netilmicin and amikacin. In terms of disease indication, the global market is segmented into tuberculosis, urinary tract infection, amoebiasis, meningitis, cystic fibrosis, and others. Route of Administration of aminoglycosides depend upon the type & site of infection. Aminoglycoside can be administered orally, injectable (parenteral), intra-mammary and topical. Gentamicin is an important product type for major bacterial infection occuring among the patients. Gentamicin market is expected to grow significantly due to low cost and reliable activity against gram-negative aerobes. Tobramycin has been found to be slightly more effective against Pseudomonas aeruginosa infections. Amikacin and gentamicin find maximum usage in veterinary medicine. According to the WHO, amikacin may be effective against some gentamicin resistant bacteria and more suitable for hospital settings where gentamicin resistance rates are high.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/13465

Geographically aminoglycoside market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global aminoglycoside market in terms of value due to increase in bacterial infections and introduction of novel, key players for production of aminoglycoside. Early-phase diagnosis and treatment of disease is expected to drive the growth of the aminoglycoside market in North America. Europe is the second largest market for aminoglycoside in terms of value as there are favourable government policies regarding health care infrastructure and awareness of population. Asia Pacific is expected to grow at higher rate due to rising population, tropical climate which initiates bacterial infections, rising awareness between patients and increasing per capita expenditure. In addition, economic growth is supporting the healthcare infrastructure improvement in developing countries such as India and China. Thus, all the above mentioned factors collectively fuel the growth of aminoglycoside market in Asia Pacific. Middle East and Africa is another major region which is projected to grow remarkably due to rise in tuberculosis and HIV disease rate among the population. According to the WHO, South Africa had one of the highest rates of drug-resistant tuberculosis (MDRTB) in the world, for which the use of 2nd line injectable anti-TB drugs are associated with sensorineural hearing loss (SNHL).

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/13465

The major players operating in the global biologic imaging reagents market include Achaogen, Inc., SelectX Pharmaceuticals, Inc., Oricula Therapeutics, Yi Chang Veterinary Medicine Factory, among other significant players worldwide.

To view complete report @ http://www.persistencemarketresearch.com/market-research/aminoglycosides-market.asp

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aminoglycosides Market Expected to Generate Huge Profits by 2017 – 2025 : Persistence Market Research here

News-ID: 591586 • Views:

More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health Trends
Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Plant-Based Demand
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenience & Demand
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Market Research
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that

All 5 Releases


More Releases for Aminoglycoside

Inhaled Aminoglycoside Formulations Market Size, Clinical Trials, Product Pipeli …
Inhaled Aminoglycoside Formulations Market Size is estimated to be $350 million in 2024 and is expected to grow at an average yearly rate of around 20% during the timeframe (2025-2032). What is Inhaled Aminoglycoside Formulations and what are the growth drivers of Inhaled Aminoglycoside Formulations Market? Inhaled aminoglycoside formulations are specialized antibiotic treatments designed to deliver aminoglycoside drugs directly to the lungs via inhalation. Aminoglycosides are potent antibiotics that are
Aminoglycoside Antibiotics Market Technology, Development Trends and Business Op …
The Aminoglycoside Antibiotics Market Is Set To Grow At An Estimated CAGR Of 4.2% From 2025 To 2034, Rising From $3.2 Billion In 2024 To $4.8 Billion By 2034. On April 22, 2025, Exactitude Consultancy., Ltd. released a research report titled "Aminoglycoside Antibiotics Market" This report offers a new perspective on the Aminoglycoside Antibiotics Market covering an extensive range of aspects including market overview, expenditure analysis, import trends, segmentation, key players,
Aminoglycoside Antibiotics Market Leading Growth Drivers, Emerging Audience, Seg …
The Aminoglycoside Antibiotics market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.  Aminoglycoside Antibiotics are the class of antibiotics specifically effective against gram negative bacterial infections.
Aminoglycoside Antibiotics Market Latest Trends and Future Growth Study by 2028 …
This report on global Aminoglycoside Antibiotics market was created using both primary and secondary research methods. During the forecast years, the Aminoglycoside Antibiotics market is expected to grow in both volume and value. This Aminoglycoside Antibiotics industry study provides insight into the market's key drivers, threats, opportunities, and restraints. The SWOT analysis and Porter's five forces analysis were done by the analysts at Infinity Business Insights to assess the impact
Analyzing Impacts Of COVID-19 On Aminoglycoside Antibiotics Market Effects, Afte …
Global Aminoglycoside Antibiotics Industry 2021 Market Research Report is an in-depth study providing a complete analysis of the Aminoglycoside Antibiotics Market for the period 2021–2027. It provides a complete overview of market size, share, growth, trends, industry chain structure, top manufacturers, market dynamics and competitive scenario. Download Sample Copy of This Report @ https://www.theinsightpartners.com/sample/TIPRE00018079/?source=openpr-10379 Development policies, investment plans, cost structures, capacity are discussed as well as growth rate, manufacturing processes, economic growth
Aminoglycoside Antibiotics Market Impressive Gains including key players Britann …
Aminoglycoside Antibiotics Market Analysis & Trends The “Aminoglycoside Antibiotics Market” 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Aminoglycoside Antibiotics Industry Report is an in-depth study analyzing the current state of the Aminoglycoside Antibiotics Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Aminoglycoside